Understanding the Current Rating
The 'Hold' rating assigned to National Peroxide Ltd indicates a neutral stance, suggesting that investors should maintain their existing positions rather than aggressively buying or selling the stock. This recommendation is based on a balanced assessment of the company's quality, valuation, financial trend, and technical indicators as of today.
Quality Assessment
As of 11 September 2026, National Peroxide Ltd's quality grade is considered below average. The company has experienced a negative compound annual growth rate (CAGR) of -1.79% in operating profits over the past five years, signalling challenges in sustaining long-term profitability growth. Additionally, the average return on equity (ROE) stands at a modest 2.75%, reflecting limited efficiency in generating profits from shareholders' funds. These factors suggest that while the company maintains operational stability, it faces hurdles in delivering robust quality metrics that typically attract higher investor confidence.
Valuation Perspective
Contrasting its quality metrics, National Peroxide Ltd presents an attractive valuation profile. The stock trades at a price-to-book (P/B) ratio of approximately 1, which is favourable compared to its peers' historical averages. This valuation discount offers potential value for investors seeking exposure to the commodity chemicals sector without paying a premium. Furthermore, the company’s ROE has improved to 5.1% recently, supporting the notion that the stock is reasonably priced relative to its earnings potential. The price-to-earnings-to-growth (PEG) ratio is notably low at 0.1, indicating that the stock’s price growth is not fully reflecting its earnings growth prospects, which could be appealing for value-oriented investors.
Financial Trend and Recent Performance
The financial trend for National Peroxide Ltd is very positive as of 11 September 2026. The company has demonstrated consistent growth in net sales, with a 12.13% increase reported in the latest quarter. This growth is complemented by strong profitability gains, with profit before tax (PBT) excluding other income reaching ₹6.70 crores, representing a 196.5% increase compared to the previous four-quarter average. Similarly, the profit after tax (PAT) for the quarter stood at ₹6.61 crores, up 104.6% over the same period. The company has declared positive results for three consecutive quarters, signalling improving operational efficiency and market demand. Net sales for the quarter hit a record ₹96.07 crores, underscoring the company’s ability to expand its revenue base amid challenging market conditions.
Technical Indicators
From a technical standpoint, National Peroxide Ltd exhibits mildly bullish signals. The stock has delivered a 6.18% return over the past month and a robust 62.92% gain over the last six months. Year-to-date returns stand at 32.26%, while the one-year return is a modest 2.75%. Despite a slight dip of 0.43% on the most recent trading day, the overall trend suggests positive momentum. These technical factors support the 'Hold' rating, indicating that while the stock is not currently a strong buy, it maintains upward potential that investors should monitor closely.
Shareholding and Market Capitalisation
National Peroxide Ltd is classified as a microcap company within the commodity chemicals sector. The majority shareholding is held by promoters, which often implies stable management control and alignment with shareholder interests. However, microcap status can also entail higher volatility and liquidity risks, factors that investors should consider when evaluating the stock.
Handpicked from 50, scrutinized by experts – Our recent selection, this Mid Cap from Bank - Public, is already delivering results. Don't miss next month's pick!
- - Expert-scrutinized selection
- - Already delivering results
- - Monthly focused approach
Implications for Investors
The 'Hold' rating on National Peroxide Ltd suggests that investors should maintain their current holdings while closely monitoring the company’s evolving fundamentals and market conditions. The attractive valuation and improving financial trends provide a foundation for potential upside, but the below-average quality metrics and microcap status warrant caution. Investors seeking exposure to the commodity chemicals sector may find this stock suitable as part of a diversified portfolio, particularly if they are comfortable with moderate risk and volatility.
Summary of Key Metrics as of 11 September 2026
To summarise, the stock’s recent performance and financial indicators include:
- Mojo Score: 56.0, reflecting a Hold grade
- Operating profit CAGR over five years: -1.79%
- Return on Equity (average): 2.75%
- Net sales growth in latest quarter: 12.13%
- Profit before tax (quarterly): ₹6.70 crores, up 196.5%
- Profit after tax (quarterly): ₹6.61 crores, up 104.6%
- Price to Book Value: 1.0, indicating attractive valuation
- PEG ratio: 0.1, signalling undervaluation relative to growth
- Stock returns: 6.18% (1 month), 62.92% (6 months), 32.26% (YTD), 2.75% (1 year)
These figures highlight a company in transition, with improving profitability and valuation metrics that justify a cautious but optimistic stance.
Looking Ahead
Investors should continue to watch National Peroxide Ltd’s quarterly results and market trends to assess whether the company can sustain its positive momentum and improve its quality metrics. The current 'Hold' rating reflects a balanced view that recognises both the opportunities and risks inherent in the stock at this stage.
Conclusion
In conclusion, National Peroxide Ltd’s 'Hold' rating by MarketsMOJO, updated on 03 August 2026, is supported by a combination of attractive valuation, positive financial trends, and mild technical bullishness, tempered by below-average quality scores and microcap risks. This rating advises investors to maintain their positions while remaining vigilant to future developments that could influence the stock’s outlook.
Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →
